摘要
IB的对味达唑仑治疗癫痫持续状态的治疗效果进行探究。方法选取我院于2012年17月-2014年10月收治的90例癫痫持续状态患者随机分成对照组和治疗组，对照组患者采用地西泮治疗，治疗组采用咪达唑仑治疗，对两组患者治疗后不良反应发生情况和临床症状进行分析比较结果经过治疗，对照组的不良反应发生率为17．8％，治疗总有效率为86．7％；治疗组的不良反应发生率为8．9％，治疗总有效率为95.6％，两组结果对比差异显著．结论采用咪达唑仑治疗癫痫持续状态治疗效果显著，并且毒副作用小，不良发应情况少。
Objective The clinical efficacy of Midazolam treatment of status epilepticus is to be analyzed. Methods Choose 90 cases status epilepticus patients who are treated in hospital from July 2012 to October 2014 and separate them into control group and study group at random. Patients in control group are given diazepam treatment. White, patients m study group are given Midazolam treatment; and then observe and compare the patients＇ side-effect condition and their clinical symptoms of two groups after the treatment. Results For patients in control group, the side-effect incidence is 17.8% and treatment efficiency is 86.7%; while, for patients in study group, the side-effect incidence is 8.9% and treatment efficiency is 95.6%, there is a treatment differential between the two groups, and such a differential has statistic value （ P〈0.05 ） . Conclusion Midazolam treatment is quite effective to enre status epilepticus with few poisoning by-effect and side effect, therefore, it is rather worthwhile to be clinically promoted and applied in treatment of status epilepticus.
出处
《中国卫生标准管理》
2015年第5期234-236,共3页
China Health Standard Management
关键词
咪达唑仑
治疗
癫痫持续状态
临床
Midazolam, Treatment, Status epilepticus, Clinical
